期刊文献+

单一使用沙利度胺治疗骨髓增生异常综合征的疗效观察 被引量:3

Treatment of Myelidysplastic Syndrome with Thalidomide
下载PDF
导出
摘要 目的探讨单一使用沙利度胺治疗骨髓增生异常综合征(MDS)的疗效。方法单一使用沙利度胺治疗MDS11例。结果疗效达部分缓解4例,进步2例,轻微反应1例,无效4例,总有效率为63.6%。结论单一使用沙利度胺对MDS有一定疗效,尤其是对难治性贫血(RA)患者可以明显缓解病情、减少输血次数、改善生活。 Objective To observe the theraputic effects and side- effects of thalidomide for the treatment of myelidysplastic syndrome(MDS). Methods A total of 11 patients with MDS were treated by thalidomide singly. Results Four of the 11 patients responded to the treatment with thalidomide. No severe side- effects were observed. Conclusion Thalidomide may be a choice for the patients with MDS.
出处 《中国药业》 CAS 2007年第11期46-47,共2页 China Pharmaceuticals
关键词 骨髓增生异常综合征 沙利度胺 疗效 myelodysplastic syndromes thalidomide curative effect
  • 相关文献

参考文献4

二级参考文献20

  • 1[1]Sezer O, Niemoller K, Eucker J, et al. Bone marr ow microvessel density is a prognostic factor for survival in patients with mult iple myeloma. Ann Hematol, 2000, 24:574-576.
  • 2[2]Perez-Atayde A, Sallan S, Tedrow U, et al. Spectrum of tumor angio genesis in the bone marrow of children with acute lymphoblastic leukemia. Am J P hthol, 1997,150:815-821.
  • 3[3]Shami P J, Hussong J W, Rodgers G M. Evidence of increased angiogenesi s in the bone marrow of patients with acute nonlymphocytic leukemia. Blood,1998, 92(suppl, 1):512-513.
  • 4[4]Bellamy W T, Ritchter L, Frutiger Y, et al. Expression of VEGF and its receptors in hematopoietic malignancies. Cancer Res, 1999, 59:728-733.
  • 5[5]Kennetb C, Anderson. Thalidomide: therapeutic potential in hematologic malignancies. Semin Hematol. 2000, 37:1-3.
  • 6[6]Singhal S, Mehta J, Desikam R, et al. Antitumor activity of thalidomid e in refractory multiple myeloma . N Engl J Med, 1999, 341:1565-1571.
  • 7[7]Verheul H M, Panigraphy D, Yuan J, et al. Combination oral antiangioge nic therapy with thalidomide and sulindac inhibits tumor growth in rabbits. Br J Cancer, 1999, 79:114-118.
  • 8[8]Liu J, Razani B, Tang S, et al. Angiogenesis activators and inh ibitors differently regulate caveolin-1 expression and caveolae formation in va scular endothelial cells angiogenesis inhibitors block vascular endothelial grow th factor-induced down-regulation of caveolin-1. J Biol Chem, 1999, 274:15781 -15785.
  • 9[9]Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and its analogs o vercome drug resistance of human multiple mueloma cells to conventional therapy. Blood, 2000, 96:2943-2950.
  • 10[10]David I, StirlingD.Pharmacology of thalidomide. Semin Hematol. 2000, 3 7(Suppl 3):5-14.

共引文献18

同被引文献35

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部